In MAFLD patients with overweight/obesity, there were dose–response relationships between moderate-to-severe steatosis and total cholesterol, triglyceride, HDL-c, LDL-c, ApoB, ApoE, and Lp(a) (all p for trend <0.05). The gene discussed is APOB; the disease is obesity disorder.